Utilization of polymeric carriers for (E)-1-(5-methyl-1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one as anticancer agent
Last updated: 01 Jan 2025
10.21608/ejchem.2023.214817.8068
1,2,3-triazole chalcone hybrid, Anticancer activity, Chitosan, CMC, controlled release
Ayda A.
Mohamed
Chemistry Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt, Faculty of Pharmacy, Horus University in Egypt, New Damietta, Egypt
aydaadel2020@gmail.com
D.M.
Ayad
Chemistry Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt
H.
Al-Subbagh
Medicinal Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
M.Y.
Abdelaal
Chemistry Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt
67
2
44642
2024-02-01
2023-06-01
2024-02-01
487
495
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_310431.html
https://ejchem.journals.ekb.eg/service?article_code=310431
310,431
Original Article
297
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
Utilization of polymeric carriers for (E)-1-(5-methyl-1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one as anticancer agent
Details
Type
Article
Created At
30 Dec 2024